R1 RCM Inc RCM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RCM is a good fit for your portfolio.
News
-
R1 RCM ALERT: Bragar Eagel & Squire, P.C. is Investigating R1 RCM Corp. on Behalf of R1 RCM Stockholders and Encourages Investors to Contact the Firm
-
Lowey Dannenberg, P.C. is Investigating R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM) for Potential Violations of the Federal Securities Laws
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of R1 RCM Inc. - RCM
-
Activist Short Seller Says R1 RCM (RCM) Creatively Manipulates Revenues- Hagens Berman
-
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of R1 RCM Inc. (RCM) on Behalf of Investors
-
R1 RCM ALERT: Bragar Eagel & Squire, P.C. is Investigating R1 RCM Corp. on Behalf of R1 RCM Stockholders and Encourages Investors to Contact the Firm
-
The Law Offices of Frank R. Cruz Continues Investigation of R1 RCM Inc. (RCM) on Behalf of Investors
-
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of R1 RCM Inc. (RCM) on Behalf of Investors
Trading Information
- Previous Close Price
- $10.71
- Day Range
- $10.38–10.87
- 52-Week Range
- $8.84–18.71
- Bid/Ask
- $9.61 / $16.57
- Market Cap
- $4.43 Bil
- Volume/Avg
- 3.5 Mil / 3.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 76.45
- Price/Sales
- 2.13
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.45%
Company Profile
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 27,800
- Website
- https://www.r1rcm.com
Valuation
|
Metric
|
RCM
|
|---|---|
Price/Earnings (Normalized) | 76.45 |
Price/Book Value | 1.61 |
Price/Sales | 2.13 |
Price/Cash Flow | 12.19 |
Price/Earnings
RCM
Financial Strength
|
Metric
|
RCM
|
|---|---|
Quick Ratio | 1.47 |
Current Ratio | 1.80 |
Interest Coverage | 0.48 |
Quick Ratio
RCM
Profitability
|
Metric
|
RCM
|
|---|---|
Return on Assets (Normalized) | 2.26% |
Return on Equity (Normalized) | 4.20% |
Return on Invested Capital (Normalized) | 4.46% |
Return on Assets
RCM
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | Pkttyt | $31.2 Bil | |
VEEV
| Veeva Systems Inc Class A | Sdjp | $28.0 Bil | |
MTHRF
| M3 Inc | Kssb | $11.3 Bil | |
MTHRY
| M3 Inc ADR | Hvyxp | $11.3 Bil | |
PMCUF
| Pro Medicus Ltd | Hkpxbzt | $6.1 Bil | |
HQY
| HealthEquity Inc | Dhhjqdq | $5.7 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | Mbnx | $5.1 Bil | |
DOCS
| Doximity Inc Class A | Zknthl | $4.3 Bil | |
PGNY
| Progyny Inc | Fhgnvx | $3.3 Bil |